36.92
5.49%
1.92
Finanzdaten der Nutex Health Inc-Aktie (NUTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
3.18%
67.45
|
69.67 | 62.72 | 58.92 | 56.33 |
Cost Of Revenue |
1.49%
57.30
|
56.46 | 55.66 | 49.28 | 51.48 |
Gross Profit |
23.13%
10.16
|
13.21 | 7.0662 | 9.6469 | 4.8477 |
Operating Expenses |
77.88%
8.7076
|
39.36 | 7.8874 | 10.01 | 9.2928 |
Interest Income/Expense |
4.91%
4.4444
|
4.2366 | 4.0982 | 4.843 | 3.1401 |
Benefits Costs and Expenses |
32.65%
67.61
|
100.38 | 67.59 | 64.01 | 64.16 |
Costs And Expenses |
42.92%
57.30
|
100.38 | 55.66 | 49.28 | 51.48 |
Depreciation and Amortization |
10.60%
4.1862
|
4.6827 | 4.7459 | 4.1692 | 3.9937 |
Operating Income/Loss |
105.54%
1.4496
|
-26.14 | -0.8212 | -0.3625 | -4.4451 |
Income/Loss From Continuing Operations Before Tax |
99.50%
-0.1528
|
-30.71 | -4.8662 | -5.0821 | -7.8326 |
Income Tax Expense/Benefit, Deferred |
97.38%
-0.0954
|
-3.6388 | -0.3444 | -0.8135 | -0.9107 |
Income Tax Expense/Benefit |
113.00%
0.3897
|
-2.9986 | -0.3423 | -0.8156 | -0.9107 |
Income/Loss From Continuing Operations After Tax |
98.04%
-0.5425
|
-27.71 | -4.5239 | -4.2664 | -6.922 |
Net Income/Loss
|
98.04%
-0.5425
|
-27.71 | -4.5239 | -4.2664 | -6.922 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
104.57%
-0.1784
|
3.9065 | 1.0185 | -0.7874 | -1.7747 |
Basic Average Shares |
1,226%
48.49
|
3.6577 | 665.06 | 656.56 | 650.92 |
Basic Earnings Per Share |
80.00%
-0.01
|
-0.05 | -0.01 | -0.01 | -0.01 |
Diluted Earnings Per Share |
80.00%
-0.01
|
-0.05 | -0.01 | -0.01 | -0.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):